{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:07:25Z","timestamp":1759961245857},"reference-count":2,"publisher":"The University of Occupational and Environmental Health, Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J UOEH"],"published-print":{"date-parts":[[2017]]},"DOI":"10.7888\/juoeh.39.11","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T22:35:22Z","timestamp":1490222122000},"page":"11-24","source":"Crossref","is-referenced-by-count":3,"title":["Reconsideration of Secondary Risk Management Strategies in Patients with Ischemic Heart Disease"],"prefix":"10.7888","volume":"39","author":[{"given":"Kuninobu","family":"KASHIYAMA","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinjo","family":"SONODA","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"OTSUJI","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4637","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"23. Dargie HJ & The CAPRICORN investigators (2001): Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 357: 1385-1390","DOI":"10.1016\/S0140-6736(00)04560-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"24. Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T & Candesartan Antihypertensive Survival Evaluation in Japan Trial Group (2008): Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 51: 393-398","DOI":"10.1161\/HYPERTENSIONAHA.107.098475"}],"container-title":["Journal of UOEH"],"original-title":["\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\uff12\u6b21\u4e88\u9632\u3092\u518d\u8003\u3059\u308b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/39\/1\/39_11\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T13:14:42Z","timestamp":1498396482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/39\/1\/39_11\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":2,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.7888\/juoeh.39.11","relation":{},"ISSN":["0387-821X","2187-2864"],"issn-type":[{"value":"0387-821X","type":"print"},{"value":"2187-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}